Last month Astra Zeneca released a whole load of pre-clinical cancer data to the public. It's a great move towards pharmacotransparency. However, their extensive 'AI' causality mining subsidiaries have probably identified anything individual researchers may hope to find. Viva la machina!
However, their extensive 'AI' causality mining subsidiaries have probably identified anything individual researchers may hope to find.
I think that's unlikely. Having more data about what drugs do is useful for a lot of individual researchers who have complex models to predict the activity of chemical substances.
Over time algorithm get better and there's more data to be aggregated.
If it's worth saying, but not worth its own post (even in Discussion), then it goes here.
Notes for future OT posters:
1. Please add the 'open_thread' tag.
2. Check if there is an active Open Thread before posting a new one. (Immediately before; refresh the list-of-threads page before posting.)
3. Open Threads should be posted in Discussion, and not Main.
4. Open Threads should start on Monday, and end on Sunday.